Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.04 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |